Boston Trust Walden Corp Sells 376 Shares of Mettler-Toledo International Inc. (NYSE:MTD)

Boston Trust Walden Corp lessened its holdings in Mettler-Toledo International Inc. (NYSE:MTD) by 1.1% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 32,942 shares of the medical instruments supplier’s stock after selling 376 shares during the period. Boston Trust Walden Corp’s holdings in Mettler-Toledo International were worth $49,403,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of the business. Park Avenue Securities LLC raised its holdings in Mettler-Toledo International by 14.6% in the 1st quarter. Park Avenue Securities LLC now owns 439 shares of the medical instruments supplier’s stock valued at $584,000 after buying an additional 56 shares during the last quarter. Wealth Enhancement Advisory Services LLC raised its stake in shares of Mettler-Toledo International by 16.9% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 1,144 shares of the medical instruments supplier’s stock valued at $1,523,000 after acquiring an additional 165 shares during the last quarter. Diversified Trust Co raised its stake in shares of Mettler-Toledo International by 24.2% during the first quarter. Diversified Trust Co now owns 4,080 shares of the medical instruments supplier’s stock valued at $5,432,000 after acquiring an additional 794 shares during the last quarter. Congress Wealth Management LLC DE lifted its holdings in shares of Mettler-Toledo International by 5.4% during the first quarter. Congress Wealth Management LLC DE now owns 10,484 shares of the medical instruments supplier’s stock worth $13,959,000 after purchasing an additional 538 shares during the period. Finally, Sumitomo Mitsui Trust Holdings Inc. grew its stake in shares of Mettler-Toledo International by 0.7% in the first quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 51,994 shares of the medical instruments supplier’s stock worth $69,219,000 after purchasing an additional 357 shares during the last quarter. Institutional investors and hedge funds own 95.07% of the company’s stock.

Mettler-Toledo International Stock Down 0.0 %

Shares of MTD opened at $1,292.77 on Friday. The business’s 50-day moving average price is $1,416.02 and its 200-day moving average price is $1,394.19. Mettler-Toledo International Inc. has a twelve month low of $928.49 and a twelve month high of $1,546.93. The stock has a market cap of $27.61 billion, a PE ratio of 36.25, a P/E/G ratio of 3.95 and a beta of 1.14.

Mettler-Toledo International (NYSE:MTD) last posted its earnings results on Thursday, August 1st. The medical instruments supplier reported $9.65 earnings per share (EPS) for the quarter, topping the consensus estimate of $9.00 by $0.65. The business had revenue of $946.75 million for the quarter, compared to analysts’ expectations of $929.13 million. Mettler-Toledo International had a net margin of 20.95% and a negative return on equity of 575.61%. The business’s revenue for the quarter was down 3.6% compared to the same quarter last year. During the same period in the prior year, the company posted $10.19 EPS. Analysts expect that Mettler-Toledo International Inc. will post 40.34 earnings per share for the current fiscal year.

Insider Activity at Mettler-Toledo International

In other Mettler-Toledo International news, insider Christian Magloth sold 1,000 shares of the company’s stock in a transaction dated Thursday, August 15th. The stock was sold at an average price of $1,422.97, for a total value of $1,422,970.00. Following the transaction, the insider now directly owns 734 shares in the company, valued at $1,044,459.98. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, CFO Shawn Vadala sold 250 shares of the firm’s stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $1,401.00, for a total value of $350,250.00. Following the sale, the chief financial officer now directly owns 4,914 shares of the company’s stock, valued at $6,884,514. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Christian Magloth sold 1,000 shares of the business’s stock in a transaction that occurred on Thursday, August 15th. The shares were sold at an average price of $1,422.97, for a total value of $1,422,970.00. Following the transaction, the insider now directly owns 734 shares in the company, valued at $1,044,459.98. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.94% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on MTD shares. JPMorgan Chase & Co. boosted their price target on shares of Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the stock a “neutral” rating in a research report on Monday, August 5th. StockNews.com upgraded shares of Mettler-Toledo International from a “hold” rating to a “buy” rating in a report on Thursday, July 11th. The Goldman Sachs Group raised their target price on Mettler-Toledo International from $1,150.00 to $1,300.00 and gave the company a “neutral” rating in a research note on Tuesday, July 9th. Wells Fargo & Company assumed coverage on Mettler-Toledo International in a research note on Tuesday, August 27th. They set an “equal weight” rating and a $1,400.00 price target on the stock. Finally, Evercore ISI increased their target price on Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the stock an “in-line” rating in a report on Tuesday, October 1st. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, Mettler-Toledo International currently has an average rating of “Hold” and a consensus price target of $1,363.75.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.